Even though our study did not provide an in-depth characterization of the mechanism underlying the TLR9–USP24–IFN axis, we postulate that the activation of pDCs in SSc patients could lead to higher miR-139-5p levels, which in turn could fine-tune USP24 expression and thereby possibly mediate IFN response. The gene discussed is USP24; the disease is systemic sclerosis.